Operating RegenMed: Development of better in-theater strategies for handling tissue-engineered organs and tissues

Jonathan M. Fishman, Justin C R Wormald, Mark W. Lowdell, Paolo De Coppi, Martin A. Birchall

Research output: Contribution to journalArticle

Abstract

Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

Original languageEnglish (US)
Pages (from-to)785-791
Number of pages7
JournalRegenerative Medicine
Volume9
Issue number6
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

    Fingerprint

Keywords

  • biotechnology
  • operating room
  • operating theater
  • reconstruction
  • regeneration
  • regenerative medicine
  • scaffold
  • stem cells
  • surgery
  • tissue engineering

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this